Silvercrest Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $4.81M | Sell |
|
|||||
|
2024
Q4 | $6.19M | Sell |
|
|||||
|
2024
Q3 | $8.18M | Sell |
|
|||||
|
2024
Q2 | $6.78M | Buy |
|
|||||
|
2024
Q1 | $4.94M | Buy |
|
|||||
|
2023
Q4 | $5.15M | Hold |
|
|||||
|
2023
Q3 | $3.83M | Sell |
|
|||||
|
2023
Q2 | $6.3M | Sell |
|
|||||
|
2023
Q1 | $5.81M | Sell |
|
|||||
|
2022
Q4 | $6.25M | Sell |
|
|||||
|
2022
Q3 | $6.33M | Sell |
|
|||||
|
2022
Q2 | $8.05M | Sell |
|
|||||
|
2022
Q1 | $8.68M | Sell |
|
|||||
|
2021
Q4 | $8.59M | Hold |
|
|||||
|
2021
Q3 | $7.01M | Sell |
|
|||||
|
2021
Q2 | $7.61M | Buy |
|
|||||
|
2021
Q1 | $5.38M | Sell |
|
|||||
|
2020
Q4 | $6.69M | Buy |
|
|||||
|
2020
Q3 | $5.27M | Sell |
|
|||||
|
2020
Q2 | $6.43M | Sell |
|
|||||
|
2020
Q1 | $4.32M | Sell |
|
|||||
|
2019
Q4 | $5.79M | Buy |
|
|||||
|
2019
Q3 | $4.58M | Buy |
|